Diagnostics
The technology is intended for those at high risk of stroke, such as stroke survivors and those diagnosed with transient ischemic attack.
Hi, what are you looking for?
TMG360 News
Diagnostics
An Edinburgh researcher working on new therapies for difficult-to-treat cancers has become one of the first recipients of $20m worth of funding from an...
BioTechnology
Cancer is not an easy target. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined...
Artificial Intelligence
Recent advancements in biotechnology have immense potential to help address many global problems; climate change, an aging society, food security, energy security, and infectious...
Clinical Trials
The REVEALPLAQUE trial is planned to enroll 250 patients with stable coronary artery disease from approximately 15 sites across the U.S. and Japan.
Diagnostics
The Penn State research group is confident that the tiny levels of glucose found in sweat can provide a meaningful correlation with the amount...
Diagnostics
Avingtrans, which designs, manufactures, and supplies critical components, modules, systems has invested £2.5 million in a £12.9 million fund raise by emerging Oxford-based medtech...
Diagnostics
The technique consists of flowing the cells through vibrating microchannels, which lets the researchers obtain single cell mass measurements in a high-throughput manner.
Artificial Intelligence
The platform includes continuous glucose monitors (CGMs), fitness watches, comprehensive blood tests and the development of each member’s individualized Whole Body Digital Twin, along...
Diagnostics
SyncThink, a neurotechnology company and developer of the EYE-SYNC technology, has received clearance from the Food and Drug Administration (FDA) for the EYE-SYNC technology...
Artificial Intelligence
Artificial Intelligence
